Castle Biosciences Inc financial data

Symbol
CSTL on Nasdaq
Industry
Services-Medical Laboratories
Location
505 S Friendswood Drive, Suite 401, Friendswood, TX
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 4, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 769 % -5.72%
Quick Ratio 18.5 % +23.5%
Debt-to-equity 15.4 % +27.5%
Return On Equity 1.47 %
Return On Assets 1.27 %
Operating Margin -0.33 % +99.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 28M shares +4.08%
Common Stock, Shares, Outstanding 28M shares +4.04%
Entity Public Float 311M USD -34.1%
Weighted Average Number of Shares Outstanding, Basic 27.8M shares +3.75%
Weighted Average Number of Shares Outstanding, Diluted 29.4M shares +9.57%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 312M USD +62.4%
Cost of Revenue 56.4M USD +34.1%
Research and Development Expense 53.3M USD +2.56%
Operating Income (Loss) -1.04M USD +98.8%
Income Tax Expense (Benefit) -918K USD -1155%
Net Income (Loss) Attributable to Parent 6.08M USD
Earnings Per Share, Basic 0.23 USD/shares
Earnings Per Share, Diluted 0.22 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 95M USD +4.1%
Accounts Receivable, after Allowance for Credit Loss, Current 50.3M USD +35.8%
Inventory, Net 6.57M USD +13.9%
Assets, Current 345M USD +23.3%
Property, Plant and Equipment, Net 22.3M USD +70.6%
Operating Lease, Right-of-Use Asset 11.9M USD +2.51%
Goodwill 10.7M USD 0%
Other Assets, Noncurrent 1.83M USD +16.9%
Assets 515M USD +18%
Accounts Payable, Current 6.81M USD -1.72%
Employee-related Liabilities, Current 27.7M USD +23.5%
Liabilities, Current 44.3M USD +21.9%
Deferred Income Tax Liabilities, Net 4.22M USD +857%
Operating Lease, Liability, Noncurrent 14.7M USD +9.35%
Other Liabilities, Noncurrent 16K USD -70.9%
Liabilities 73.5M USD +46.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax 473K USD
Retained Earnings (Accumulated Deficit) -210M USD +2.82%
Stockholders' Equity Attributable to Parent 441M USD +14.3%
Liabilities and Equity 515M USD +18%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.84M USD +73.1%
Net Cash Provided by (Used in) Financing Activities 10.6M USD +1362%
Net Cash Provided by (Used in) Investing Activities -19.7M USD -219%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 28M shares +4.04%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -15.9M USD -95.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 95M USD +4.1%
Deferred Tax Assets, Valuation Allowance 55M USD +10.2%
Deferred Tax Assets, Gross 79.5M USD +3.73%
Operating Lease, Liability 15.3M USD +15%
Depreciation 4.42M USD +47.6%
Payments to Acquire Property, Plant, and Equipment 9.15M USD +174%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6.62M USD
Lessee, Operating Lease, Liability, to be Paid 24.3M USD +4.37%
Operating Lease, Liability, Current 1.75M USD +59.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.25M USD +6.08%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.33M USD +26.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +13.7%
Deferred Income Tax Expense (Benefit) 0 USD -100%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 9M USD -9.85%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.24M USD +11%
Deferred Tax Assets, Operating Loss Carryforwards 47.2M USD -4.25%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.46M USD +12.7%
Additional Paid in Capital 650M USD +8.09%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 9.04M USD +0.89%
Depreciation, Depletion and Amortization 3.34M USD +15.5%
Deferred Tax Assets, Net of Valuation Allowance 24.5M USD -8.31%
Share-based Payment Arrangement, Expense 50.7M USD +2.72%
Interest Expense 424K USD +3162%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%